Use of electronic health record data for drug safety signal identification: a scoping review

SE Davis, L Zabotka, RJ Desai, SV Wang, JC Maro… - Drug Safety, 2023 - Springer
Introduction Pharmacovigilance programs protect patient health and safety by identifying
adverse event signals through postmarketing surveillance of claims data and spontaneous …

Use of Electronic Health Record Data for Drug Safety Signal Identification: A Scoping Review

SE Davis, L Zabotka, RJ Desai, SV Wang… - Drug …, 2023 - pubmed.ncbi.nlm.nih.gov
Introduction Pharmacovigilance programs protect patient health and safety by identifying
adverse event signals through postmarketing surveillance of claims data and spontaneous …

Use of Electronic Health Record Data for Drug Safety Signal Identification: A Scoping Review

SE Davis, L Zabotka, RJ Desai, SV Wang… - Drug …, 2023 - econpapers.repec.org
Introduction Pharmacovigilance programs protect patient health and safety by identifying
adverse event signals through postmarketing surveillance of claims data and spontaneous …

Use of Electronic Health Record Data for Drug Safety Signal Identification: A Scoping Review

SE Davis, L Zabotka, RJ Desai, SV Wang, JC Maro… - Drug Safety, 2023 - ideas.repec.org
Introduction Pharmacovigilance programs protect patient health and safety by identifying
adverse event signals through postmarketing surveillance of claims data and spontaneous …

Use of Electronic Health Record Data for Drug Safety Signal Identification: A Scoping Review.

SE Davis, L Zabotka, RJ Desai, SV Wang, JC Maro… - Drug Safety, 2023 - europepmc.org
Methods To evaluate the current state of EHR-based medication safety signal identification,
we conducted a scoping literature review of studies aimed at identifying safety signals from …